Post Profile

Shares Of Lannett Tumble After FDA Moves To Withdraw Approval Of Generic ADHD Drug

Shares of Lannett plunged by 12.9% on Monday after the Food & Drug Administration said it planned to withdraw approval of its generic treatment for attention deficit hyperactivity disorder. The FDA wants to withdraw approval of an abbreviated new drug application for methylphenidate hydrochloride extended-release tablets marketed by Lannett and a larger drug company, Mallinckrodt. […]
read more

See more about: Drug Administration

Related Posts

Kids taking fewer antibiotics, more ADHD meds

Health : The Chart

American children are taking fewer antibiotics now than 10 years ago, but prescriptions to treat attention deficit hyperactivity disorder, or ADHD, have increased, according to a new report by the Food and Drug Administration. FDA r...

Lack Of ADHD Med Ingredients Make Patients Jumpy; FDA, DEA Involved

Health : Medical News Today

It seems there is a shortage of the ingredients needed to produce attention deficit hyperactivity disorder (ADHD) medications, and has sent some patients into a panic. The Food and Drug Administration discovered in March that they d...

New ADHD Test Uses Brainwaves

Health : Medical News Today

A new test of brain waves measured by electroencephalogram (EEG) has been approved for helping to diagnose whether a child has attention deficit hyperactivity disorder (ADHD). The US Food and Drug Administration (FDA) today gave the...

Review of ADHD drug approvals highlights gaps between approval process, long-term safety assessment

Academics / General Science : Science Codex

BOSTON – Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term effica...

Fake Adderall Sold Online, FDA Warns

Health : Time: Healthland

On Tuesday, the U.S. Food and Drug Administration (FDA) warned that fake versions of Adderall — a drug used for the treatment of attention deficit hyperactivity disorder, or ADHD, and narcolepsy — are being sold online. The FDA says...


Copyright © 2016 Regator, LLC